PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
26.51%
Growth of 26.51% versus flat Healthcare revenue. Walter Schloss would verify growth quality.
-25.60%
Cost reduction while Healthcare median is 1.21%. Seth Klarman would investigate competitive advantage potential.
674.09%
Growth of 674.09% versus flat Healthcare gross profit. Walter Schloss would verify quality.
553.78%
Margin change of 553.78% versus flat Healthcare margins. Walter Schloss would verify quality.
5.26%
R&D change of 5.26% versus flat Healthcare spending. Walter Schloss would verify adequacy.
22.50%
G&A change of 22.50% versus flat Healthcare overhead. Walter Schloss would verify efficiency.
22.03%
Marketing expense change of 22.03% versus flat Healthcare spending. Walter Schloss would verify adequacy.
-170.92%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
12.97%
Operating expenses growth exceeding 1.5x Healthcare median of 0.49%. Jim Chanos would check for waste.
-12.98%
Total costs reduction while Healthcare median is 2.77%. Seth Klarman would investigate advantages.
383.37%
Interest expense change of 383.37% versus flat Healthcare costs. Walter Schloss would verify control.
-14.14%
D&A reduction while Healthcare median is 0.00%. Seth Klarman would investigate efficiency.
96.30%
EBITDA change of 96.30% versus flat Healthcare. Walter Schloss would verify quality.
89.69%
Margin change of 89.69% versus flat Healthcare. Walter Schloss would verify quality.
92.54%
Income change of 92.54% versus flat Healthcare. Walter Schloss would verify quality.
94.11%
Margin change of 94.11% versus flat Healthcare. Walter Schloss would verify quality.
-12647.40%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
90.74%
Pre-tax income growth while Healthcare declines. Peter Lynch would examine advantages.
92.68%
Margin change of 92.68% versus flat Healthcare. Walter Schloss would verify quality.
175.22%
Tax expense change of 175.22% versus flat Healthcare. Walter Schloss would verify strategy.
89.98%
Income change of 89.98% versus flat Healthcare. Walter Schloss would verify quality.
92.08%
Margin change of 92.08% versus flat Healthcare. Walter Schloss would verify quality.
90.72%
EPS change of 90.72% versus flat Healthcare. Walter Schloss would verify quality.
90.72%
Diluted EPS change of 90.72% versus flat Healthcare. Walter Schloss would verify quality.
6.68%
Share count reduction below 50% of Healthcare median of 0.04%. Jim Chanos would check for issues.
6.68%
Diluted share reduction below 50% of Healthcare median of 0.01%. Jim Chanos would check for issues.